TIL Immunotherapy Treatment for Ovarian Cancer in Israel

TIL Immunotherapy treatment is an innovative treatment for patients with ovarian cancer that has not responded sufficiently to conventional therapies. TIL (Tumor Infiltrating Lymphocytes) treatment has already demonstrated encouraging results as an effective therapy for melanoma. In January 2018, Sheba Medical Center opened clinical trials that implement TIL as a way to treat ovarian cancer, and we are currently the only hospital worldwide to offer this revolutionary therapy – still in active research.

Get Consultation Now

We are here to help

By submitting this form you agree to have your information used for consultation purposes only in accordance with our Privacy Policy.